EUVIMEDEUVIMED entdecken
Crossref

Scutellarin ameliorates PCOS in a mouse model by restoring mitochondrial function and inhibiting granulosa cell apoptosis

Zhi Li iD, Xiaoping Yang, Weifen Deng, Yudong Liu, Peixuan Lan, Yibo Song, Yanqiu Xie, Yuhua Shi iD

Journal of Endocrinology · 01.08.2026 · 270 (2)

DOI: 10.1530/joe-25-0429 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Endocrinology, online erschienen am 03.08.2026. Verfasst von Zhi Li und 7 weiteren Autor:innen. Beteiligte Einrichtung: Guangdong Cardiovascular Institute, Guangdong Provincial People's Hospital, Ganzhou Hospital, Guangdong Academy of Medical Sciences , Guangzhou, Chin…. Hauptthemen laut MEDLINE: Polycystic Ovary Syndrome, Apigenin, Apoptosis, Granulosa Cells. Die Arbeit nennt 46 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Polycystic ovary syndrome (PCOS), a common endocrine–metabolic disorder, lacks effective therapeutic options. Granulosa cell (GC) apoptosis and mitochondrial dysfunction are critical drivers of ovarian dysfunction in PCOS, yet targeted therapies are scarce. Scutellarin, a bioactive flavonoid, is a promising but unexplored candidate for treating PCOS. We investigated scutellarin’s effects in a dehydroepiandrosterone (DHEA)-induced PCOS mouse model and in DHEA-treated human granulosa-like KGN cells. We assessed metabolic and reproductive parameters, ovarian histology, and fertility and examined molecular mechanisms using transcriptomics, qRT-PCR, and western blotting. Apoptosis and mitochondrial function were evaluated via TUNEL staining, flow cytometry, and real-time mitochondrial assays. We found that scutellarin treatment was associated with improved metabolic phenotypes in PCOS mice, including glucose intolerance and insulin resistance, a normalized estrous cycle, lower serum testosterone and luteinizing hormone levels, better ovarian morphology, and enhanced fertility. Mechanistically, scutellarin correlated with reduced ovarian GC apoptosis and modulation of BCL2, BAX, and cleaved caspase-3. Transcriptomic analysis identified the PI3K/Akt signaling pathway as a key mediator, and scutellarin dampened its abnormal activation in DHEA-induced PCOS in vivo and in vitro. Furthermore, scutellarin was associated with improved mitochondrial function in DHEA-treated KGN cells, evidenced by reduced ROS production and restored membrane potential. We conclude that scutellarin is associated with the amelioration of metabolic and reproductive abnormalities in a PCOS mouse model, correlating with reduced GC apoptosis and improved mitochondrial function. By modulating these cellular defects, scutellarin offers potential dual benefits on ovarian and systemic dysfunctions, highlighting its value for clinical investigation and providing novel mechanistic insights.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Polycystic Ovary SyndromeApigeninApoptosisGranulosa CellsGlucuronatesMitochondriaAnimalsFemaleMiceHumansDisease Models, AnimalDehydroepiandrosteroneSignal TransductionOvary

Stichwörter der Autor:innen

granulosa cell apoptosismitochondrial dysfunctionovarian homeostasispolycystic ovary syndromescutellarin

Substanzen

scutellarinApigeninGlucuronatesDehydroepiandrosterone

Autor:innen und Institutionen

  • Guangdong Cardiovascular Institute, Guangdong Provincial People's Hospital, Ganzhou Hospital, Guangdong Academy of Medical Sciences , Guangzhou, China.
  • Department of Reproductive Medicine, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University , Guangzhou, China.
  • Department of Reproductive Medicine, Nanfang Hospital, Southern Medical University , Guangzhou, China.
  • Reproductive Medicine Centre, Shenzhen Hengsheng Hospital , Shenzhen, China.

ORCID-Profile: Zhi Li, Yuhua Shi

Zitieren

APA

Li, Z., Yang, X., Deng, W., Liu, Y., Lan, P., Song, Y., Xie, Y., & Shi, Y. (2026). Scutellarin ameliorates PCOS in a mouse model by restoring mitochondrial function and inhibiting granulosa cell apoptosis. Journal of Endocrinology, 270(2). https://doi.org/10.1530/joe-25-0429

Vancouver

Li Z, Yang X, Deng W, Liu Y, Lan P, Song Y, et al. Scutellarin ameliorates PCOS in a mouse model by restoring mitochondrial function and inhibiting granulosa cell apoptosis. Journal of Endocrinology. 2026;270(2). doi:10.1530/joe-25-0429

BibTeX
@article{Li2026,
  author = {Li, Zhi and Yang, Xiaoping and Deng, Weifen and Liu, Yudong and Lan, Peixuan and Song, Yibo and Xie, Yanqiu and Shi, Yuhua},
  title = {Scutellarin ameliorates PCOS in a mouse model by restoring mitochondrial function and inhibiting granulosa cell apoptosis},
  journal = {Journal of Endocrinology},
  year = {2026},
  volume = {270},
  number = {2},
  doi = {10.1530/joe-25-0429}
}
Kostenlos starten →